TuisFOLD • NASDAQ
add
Amicus Therapeutics, Inc.
Vorige sluiting
$8,02
Dagwisseling
$7,92 - $8,11
Jaarwisseling
$5,51 - $12,65
Markkapitalisasie
2,46 mjd USD
Gemiddelde volume
4,20 m
P/V-verhouding
-
Dividend-opbrengs
-
Primêre beurs
NASDAQ
Marknuus
Finansieel
Inkomstestaat
Inkomste
Netto inkomste
| (USD) | Jun. 2025info | J/J-verandering |
|---|---|---|
Inkomste | 154,69 m | 22,12% |
Bedryfskoste | 147,24 m | 46,60% |
Netto inkomste | -24,42 m | -55,57% |
Netto winsgrens | -15,79 | -27,44% |
Wins per aandeel | 0,01 | -83,33% |
EBITDA | -5,92 m | -134,52% |
Effektiewe belastingkoers | -27,31% | — |
Balansstaat
Totale bates
Totale aanspreeklikheid
| (USD) | Jun. 2025info | J/J-verandering |
|---|---|---|
Kontant en korttermynbeleggings | 231,00 m | -11,18% |
Totale bates | 815,30 m | 8,78% |
Totale aanspreeklikheid | 611,00 m | -0,97% |
Totale ekwiteit | 204,30 m | — |
Uitstaande aandele | 308,24 m | — |
Prys om te bespreek | 12,15 | — |
Opbrengs op bates | -2,42% | — |
Opbrengs op kapitaal | -3,02% | — |
Kontantvloei
Netto kontantverandering
| (USD) | Jun. 2025info | J/J-verandering |
|---|---|---|
Netto inkomste | -24,42 m | -55,57% |
Kontant van bedrywe | -26,53 m | -216,90% |
Kontant van beleggings | -5,78 m | 73,71% |
Kontant van finansiering | -400,00 k | 53,33% |
Netto kontantverandering | -22,72 m | -5 098,40% |
Beskikbare kontantvloei | -26,52 m | -174,72% |
Meer oor
Amicus Therapeutics, Inc. is a public American biopharmaceutical company based in Philadelphia, PA. The company went public in 2007 under the NASDAQ trading symbol FOLD. This followed a 2006 planned offering and subsequent withdrawal, which would have established the trading symbol as AMTX Prior to their IPO, Amicus was funded by a variety of venture capital firms including Radius Ventures, Canaan Partners and New Enterprise Associates. Wikipedia
Gestig
04 Feb. 2002
Webwerf
Werknemers
499
